SEOM clinical guideline for secondary prevention (2019)

Cancer is one of the major public health problems in our society. It is estimated that more than 18 million new cases are diagnosed worldwide every year; 280,000 in Spain. Incidence in following a growing trend. This epidemic could be controlled with research into new treatments and, above all, with adequate prevention. Primary prevention could prevent avoid up to half of all cases. For many others, secondary prevention is essential, as it make diagnosis possible in the stages of the disease when it is easily curable. These guidelines present the scientific evidence regarding secondary prevention in tumors in which its use is well-accepted: breast, cervical, colorectal, prostate, lung, ovarian, melanoma, and gastric cancer.     

《仁斋直指方论》“五藏所主”学术思想研究

南宋·杨士瀛《仁斋直指方论》以内科杂病、外科、妇科证治为纲,广撷诸家名方及家传良方,识证施方清晰独到,善于灵活化裁经典名方,是一部颇具影响的临床参考书。书中提出"五藏各有所主,至其病证莫不随所主而见焉",强调五脏所主与天地自然之气相应,外之六气相乘、内之七情相感皆为五脏之邪。五脏所主内涵丰富,内藏神志,上应官窍,外应肢体。五脏病证以五脏所主、虚实、阴阳为纲辨治,脏病属阴,腑病属阳,贼风客邪阳受之,饮食居室阴受之,复杂病证以病证表现、脉象特点细加辨别。诊察五脏之脉、五脏之色,可判明脏气郁畅、四时平贼、形气逆顺,诊察脉形、脉位以辨别病所、病性,亦需圆机活法,诊视相参;证治尤重五脏所主、五脏相关,依脏气虚实而补泻,依六气标本而调治,依火、湿、热、痰而祛邪,依脏腑相关而主次论治。     

光叶决明中1个新的二聚苯丙素类化合物

目的对决明属植物光叶决明Cassia floribunda茎叶的化学成分进行研究。方法运用硅胶、MCI、RP-18、TLC、HPLC等多种色谱技术进行分离纯化,根据理化性质和波谱数据鉴定化合物的结构。结果从光叶决明90%乙醇提取物中分离得到18个化合物,分别鉴定为决明顺反二聚苯丙素(1)、反式对羟基肉桂酸乙酯(2)、shonanin(3)、邻苯二甲酸二丁酯(4)、1,6,8-三羟基-3-甲基蒽醌(5)、2,5-二甲基-7-羟基-色原酮(6)、2-(2′-羟丙基)-5-甲基-7-羟基色酮(7)、4′,7-二羟基-5-甲氧基黄酮(8)、柯伊利素(9)、山柰酚(10)、芹菜素(11)、3-甲氧基槲皮素(12)、6-demethoxycapillarisin(13)、7,4′-二羟基黄酮(14)、木犀草素(15)、butin(16)、甘草素(17)和圣草酚(18)。结论化合物1为新的苯丙素类化合物;化合物2～18均为首次从该植物中分离得到,其中,化合物2～4、8、9、11、13、14、16～18为首次从决明属植物中分离得到。     

Reconstruction for axillary hidradenitis suppurativa using one‐stage local tissue rearrangement: A retrospective analysis of 53 cases

Wide local excision offers a potential cure for severe axillary hidradenitis suppurativa. However, the gold standard for reconstruction has yet to be defined. Here, we describe our rotation advancement flap technique, which allows for one‐stage closure of large axillary defects, with minimal functional morbidity to the axilla. We performed a retrospective review of all patients who underwent one‐stage surgical management for axillary hidradenitis suppurativa at a single‐centre tertiary care hospital from 2009 to 2018. We identified 34 patients, with a total of 53 operative sites. The majority were female (85%) with a mean age of 31 years and body mass index 35 kg/m². The median defect size was 84 cm² and the majority were treated using the rotation advancement flap technique (86%). A quarter of operative sites experienced minor complications with only one requiring re‐operation. At a median follow‐up of 32 months, two (4%) sites showed decreased range of motion. However, all patients had achieved remission without any further recurrence of disease. We describe a one‐stage rotation advancement flap technique for management of moderate to severe hidradenitis suppurativa that achieves a high local cure rate, minimal functional morbidity, and acceptable wound complication rates.